Richter, J. Lübking, A. Söderlund, S. Lotfi, K. Markevärn, B. Själander, A. Stenke, L. Deneberg, S. Ahlstrand, E. Myhr-Eriksson, K. Panayiotidis, P. Gedde-Dahl, T. Žáčková, D. Mayer, J. Olsson-Strömberg, U. Mahon, F.-X. Saussele, S. Hjorth-Hansen, H. Koskenvesa, P., Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI, Leukemia Research, (35), 2416-2418, 2021, Springer Nature BV, 0145-2126